Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses-Reference-Cited by-同舟云学术

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

Published:2010-09-01 Issue:1 Volume:55 Page:39-48
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Lennox Jeffrey L,DeJesus Edwin,Berger Daniel S,Lazzarin Adriano,Pollard Richard B,Ramalho Madruga Jose Valdez,Zhao Jing,Wan Hong,Gilbert Christopher L,Teppler Hedy,Rodgers Anthony J,Barnard Richard J O,Miller Michael D,DiNubile Mark J,Nguyen Bach-Yen,Leavitt Randi,Sklar Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference19 articles.

1. The cost effectiveness of combination antiretroviral therapy for HIV disease.;Freedberg;N Engl J Med,2001

2. The prevalence of antiretroviral drug resistance in the United States.;Richman;AIDS,2004

3. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance.;Truong;AIDS,2006

4. Transmission of drug-resistant HIV-1 is stabilizing in Europe.;Vercauteren;J Infect Dis,2009

5. Time trends for HIV-1 antiretroviral resistance among antiretroviral-experienced and -naive pregnant women in New York City during 1991 to early 2001.;Welles;J Acquir Immune Defic Syndr,2007

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of integrase strand transfer inhibitors among treatment-naive people living with HIV/AIDS in Guangdong, China: A real-world, retrospective cohort study;Medicine;2024-06-07

2. Efficacy and effect on lipid profiles of switching to ainuovirine-based regimen versus continuing efavirenz-based regimen in people with HIV-1: 24-week results from a real-world, retrospective, multi-center cohort study;Antimicrobial Agents and Chemotherapy;2024-04-03

3. Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial;Open Forum Infectious Diseases;2024-01-22

4. Effectiveness of integrase strand transfer inhibitors among treatment-naive HIV-infected patients in China: A retrospective real-world study;2023-11-30

5. Risks of metabolic syndrome in the ADVANCE and NAMSAL trials;Frontiers in Reproductive Health;2023-09-18